Type 2 diabetes and the metabolic syndrome in children and adolescents.
The prevalence rates of obesity, metabolic syndrome, and type 2 diabetes in children are increasing at an alarming rate. The potential impact of these conditions on the individual, the family, and society, especially in regard to the costs and utilization of health care resources, are very serious. Strategies aimed at reducing caloric intake, increasing caloric expenditure through regular exercise, and treating cardiovascular risk factors and type 2 diabetes early and aggressively are necessary to meet the challenges they impose.
Cara
José F
JF
Pfizer Global Pharmaceuticals, Pfizer, Inc., 235 East 42 Street, New York, NY 10017, USA. jose.cara@pfizer.com
Chaiken
Rochelle L
RL
D000293:Adolescent; D015992:Body Mass Index; D002648:Child; D003924:Diabetes Mellitus, Type 2; D002149:Energy Intake; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome; D009765:Obesity / Q000150:complications* / Q000453:epidemiology; D012016:Reference Values